The purpose of this study was to evaluate the effect of a BRCA mutation on survival and recurrence rate, focusing on risk of ipsilateral recurrence and contralateral breast cancer in breast cancer patients who underwent genetic screening for a BRCA1/2 mutation and were treated at the Samsung Medical Center. The gene discussed is BRCA1; the disease is breast cancer.